The UT Southwestern Cancer Genetics Program, in partnership with the Division of Digestive and Liver Diseases, provides specialized care for patients with high-risk gastrointestinal malignancies.
Recently, Angelina Jolie informed the world through two New York Times opinion articles that she had her breasts and ovaries removed after learning she had a BRCA1 mutation.
The purpose of the tumor board is to provide a multidisciplinary review of somatic (tumor) testing for the purposes of clarifying the potential implications of a patient’s results.
The Cancer Genetics program works closely with pediatric oncologists at Children’s Health to provide cancer genetics services to pediatric patients in Dallas.
Screening family histories to identify patients with Hereditary Breast and Ovarian Cancer syndrome (HBOC) has recently been classified as a Tier 1 health application by the Centers for Disease Control (CDC).
In addition to seeing patients in person in the cancer center, UT Southwestern is seeking ways to expand beyond the boundaries of the cancer center to offer genetic counseling services to much of North Texas.